Myda Advisors LLC Fulcrum Therapeutics, Inc. Transaction History

Myda Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$3.18 - $6.86 $65,603 - $141,521	-20,630 Reduced 41.26%	29,370 $198,000
Q2 2023 Aug 11, 2023	BUY	$2.26 - $3.8 $112,999 - $190,000	50,000 New	50,000 $165,000
Q3 2021 Nov 12, 2021	SELL	$7.28 - $30.97 $182,000 - $774,250	-25,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $74,937 - $111,156	9,263 Added 58.86%	25,000 $262,000
Q1 2021 May 12, 2021	BUY	$10.94 - $15.32 $172,162 - $241,090	15,737 New	15,737 $185,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.